Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...

In July, the FDA issued a complete response letter (CRL) for Replimune's biologics license application for RP1 (vusolimogene ...

First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...

Loqtorzi (toripalimab) showed significant improvement in progression-free survival for acral melanoma compared to standard chemotherapy in a phase 3 trial. Acral melanoma, a rare and aggressive ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

On November 11, 2025, CheckMySpot(R) , the Direct Access Platform(TM) for early skin cancer detection, was honored during the 2025 National Alliance of Healthcare Purchaser Coalitions Annual Forum ...

While sunbeds may be tempting, skin cancer survivor Emma Giannuzzi, 36, is urging people to use fake tanning products instead ...

When doctors showed Ross Leeder a scan revealing a mass in his brain after persistent headaches, vomiting and dizziness, he ...

SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for dermatology, ...

Recent findings reveal Cornell prime dots can activate the immune system against melanoma, improving cancer immunotherapy ...

Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...